Trimethoprim-Sulfamethoxazole–Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System

Archives of Internal Medicine
doi 10.1001/archinternmed.2010.142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Renin Angiotensin Aldosterone System Inhibitors and Hyperkalemia in Acute Heart Failure

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Severe Hyponatremia and Hyperkalemia Induced by Trimethoprim-Sulfamethoxazole in Patients With Pneumocystis Carinii Pneumonia.

Internal Medicine
Internal MedicineMedicine
1995English

Hyponatremia and/or Hyperkalemia in Patients Treated With the Standard Dose of Trimethoprim-Sulfamethoxazole

Internal Medicine
Internal MedicineMedicine
2003English

Perioperative Use of Renin-Angiotensin System Inhibitors and Outcomes in Patients Undergoing Cardiac Surgery

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Perioperative Use of Renin-Angiotensin System Inhibitors and Outcomes in Patients Undergoing Cardiac Surgery

2018English

Sulfamethoxazole/Trimethoprim Induced Liver Failure: A Case Report

Cases Journal
2008English

Use of Renin-Angiotensin System Inhibitors Is Associated With Reduction of Fracture Risk in Hemodialysis Patients

PLoS ONE
Multidisciplinary
2015English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Renin–angiotensin System Inhibitors in Patients With Coronary Artery Disease Who Have Undergone Percutaneous Coronary Intervention

Therapeutic Advances in Cardiovascular Disease
Cardiovascular MedicinePharmacologyCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy